Vanda Pharmaceuticals Inc (VNDA)
4.63
+0.13
(+2.89%)
USD |
NASDAQ |
Oct 04, 16:00
4.62
-0.01
(-0.22%)
Pre-Market: 20:00
Vanda Pharmaceuticals Shareholders Equity (Annual): 544.91M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 544.91M |
| December 31, 2022 | 527.20M |
| December 31, 2021 | 504.93M |
| December 31, 2020 | 453.27M |
| December 31, 2019 | 410.94M |
| December 31, 2018 | 275.42M |
| December 31, 2017 | 131.39M |
| December 31, 2016 | 131.33M |
| December 31, 2015 | 133.03M |
| December 31, 2014 | 160.82M |
| Date | Value |
|---|---|
| December 31, 2013 | 44.12M |
| December 31, 2012 | 9.905M |
| December 31, 2011 | 33.47M |
| December 31, 2010 | 37.73M |
| December 31, 2009 | 23.03M |
| December 31, 2008 | 46.02M |
| December 31, 2007 | 83.73M |
| December 31, 2006 | 26.76M |
| December 31, 2005 | 30.66M |
| December 31, 2004 | 15.94M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
410.94M
Minimum
2019
544.91M
Maximum
2023
488.25M
Average
504.93M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Zevra Therapeutics Inc | 61.86M |
| Edgewise Therapeutics Inc | 318.83M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |